Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
60.26
-0.84 (-1.37%)
Mar 20, 2026, 3:00 PM CST

SHA:688621 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,6776,7924,2227,8128,1929,728
Market Cap Growth
59.70%60.85%-45.95%-4.64%-15.79%-
Enterprise Value
6,5626,6774,0277,5617,8899,536
Last Close Price
61.1062.1537.5969.2672.1385.40
PE Ratio
34.1334.6423.8042.2852.3592.07
Forward PE
-30.3212.2924.1841.5879.34
PS Ratio
5.485.583.928.3812.1119.71
PB Ratio
5.735.833.837.399.0212.64
P/TBV Ratio
5.906.003.957.759.4513.28
P/FCF Ratio
--2749.41392.5389126.792953.42
P/OCF Ratio
--131.8784.1378.80110.23
EV/Sales Ratio
5.395.483.738.1111.6619.32
EV/EBITDA Ratio
28.5829.0819.9635.0945.5672.53
EV/EBIT Ratio
32.1432.7022.8439.0850.5379.49
EV/FCF Ratio
--2621.91379.9185835.422895.08
Debt / Equity Ratio
0.510.510.410.420.280.27
Debt / EBITDA Ratio
2.562.562.031.881.321.40
Debt / FCF Ratio
--296.7922.442802.1262.76
Net Debt / Equity Ratio
-0.10-0.10-0.14-0.26-0.40-0.57
Net Debt / EBITDA Ratio
-0.51-0.51-0.79-1.27-2.10-3.36
Net Debt / FCF Ratio
---104.03-13.78-3965.47-133.93
Asset Turnover
--0.560.560.500.61
Inventory Turnover
--36.4829.9729.5632.55
Quick Ratio
--1.801.691.932.15
Current Ratio
--1.951.782.012.25
Return on Equity (ROE)
17.29%17.29%15.65%18.61%18.91%22.61%
Return on Assets (ROA)
--5.72%7.27%7.21%9.21%
Return on Invested Capital (ROIC)
19.01%20.01%19.62%27.57%33.58%49.08%
Return on Capital Employed (ROCE)
--14.60%17.60%16.50%14.50%
Earnings Yield
2.94%2.89%4.20%2.37%1.91%1.09%
FCF Yield
--0.04%0.26%0.00%0.03%
Dividend Yield
0.27%-0.43%0.24%0.59%0.22%
Payout Ratio
--21.51%30.05%17.24%1.18%
Buyback Yield / Dilution
2.44%2.44%-0.28%-0.19%-14.09%-16.84%
Total Shareholder Return
2.70%2.44%0.16%0.05%-13.50%-16.62%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.